The lymphoid tissue in the gut is an early site for viral replication and the establishment of viral reservoirs. While antiretroviral drugs effectively suppress viral replication, they do not repair the damage caused by the virus to the immune system. On their own, these drugs cannot restore the functionality of the lymphoid follicles damaged by HIV infection. The researchers administered bone marrow-derived MSC in a rhesus macaque model of AIDS that had impaired immunity and disrupted gut functions due to the viral infection.
The study found that the MSCs can modulate, alter and remodel the damaged mucosal site. There were immediate benefits, with a rapid rise in antibodies and T-immune cells targeting the virus. The stem cells were instrumental in the recovery and restoration of these lymphoid follicles. The antiretroviral drugs can stop the fire of the viral infection but cannot restore the forest of the lymphoid tissue compartment.
MSC treatments require well defined cell quality controls and specific delivery mechanisms. Findings from this study provide a scientific basis for investigating MSC in treating HIV and other infectious diseases in the clinical setting. Here we show that a high-affinity T-cell population that targets mycobacterial glycolipids is disrupted by HIV infection. Whether these cells are mere bystanders of bulk CD4 depletion or whether their loss either predicts incident tuberculosis or contributes to it remain important questions for future study.
Tetramers might have failed to detect antigen-specific T cells during active infection, owing to downregulation of the T-cell receptor; our findings, as well as those from studies of bacille Calmette-Guerin infection in mice [ 15 ], suggest that is not the case. We had considered that antigen-specific T cells might home to infected tissues and not be detectable in the peripheral circulation; our findings and those from studies of mycolic acid—reactive T cells [ 11 ] show that these cells can in fact be detected in the periphery during active infection.
Whether TCR use or other aspects of surface phenotype [ 2 ] or effector function [ 7 ] correlate with latency or active disease are fascinating questions that remain to be answered. In conclusion, CD1b tetramer—positive cells express surface receptors that make them targets of HIV infection and are difficult to detect during chronic HIV infection. These findings provide an unexpected connection between HIV and a newly defined population of mycobacteria-specific T cells.
Whether these cells impact antimycobacterial immunity and whether their effects are direct, owing to cognate interactions with CD1b-expressing targets, or indirect, via cytokine secretion and activation of other cellular subsets, including peptide-specific T cells, is an area to be actively explored prior to harnessing glycolipid-reactive T cells in future tuberculosis vaccines. Consisting of data provided by the author to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the author, so questions or comments should be addressed to the author.
We thank the study subjects, for their generous participation; the study staff, for their hard work; and the Harvard CFAR, for input into statistical analysis. Financial support. Potential conflicts of interest. All authors: No reported conflicts. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. National Center for Biotechnology Information , U. J Infect Dis. Published online Sep Victoria O. Branch Moody , 6 and Anne G. Kasmar 6, a. Branch Moody.
Anne G. Author information Article notes Copyright and License information Disclaimer. Correspondence: A. Journal of Clinical Investigation. T cell dynamics in HIV-1 infection. Annual Review of Immunology. HIV accomplices and adversaries in macrophage infection.
Journal of Leukocyte Biology. Role for plasmacytoid dendritic cells in anti-HIV innate immunity. Immunology and Cell Biology. Innate signaling in HIV-1 infection of dendritic cells. Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus HIV Current HIV Research. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.
Detection of HIV gp in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. Kedzierska K, Crowe SM. Cytokines and HIV interactions and clinical implications. Antiviral Chemistry and Chemotherapy. HIV-1 Tat protein mimicry of chemokines. Experimental Cell Research. Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells.
Journal of Neuroinflammation. Journal of Interferon Research. Chen W, Royer William E. Structural insights into interferon regulatory factor activation.
Cellular Signalling. Multiple effects of interferon on the replication of human immunodeficiency virus type 1. Antiviral Research. Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages.
Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons. Scientific Reports. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nature Immunology. Innate sensing of HIV-infected cells. Geijtenbeek TBH. Reviews in Medical Virology. Virology Journal. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR.
Journal of Biological Chemistry. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. Cellular Immunology. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients.
PloS ONE. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells.
Human Immunology. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. Nature Genetics. Viral immune evasion: a masterpiece of evolution. Ahmad A, Ahmad R. Collins KL, Baltimore D. Immunological Reviews.
Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression. Antiviral Therapy. HIV-1 tat inhibits human natural killer cell function by blocking L-type calcium channels. Journal of Infectious Diseases. The capsid is taken up by an endosome, and a change in the pH value in the phagosome induces the release of the capsid contents into the cytoplasm [ 42 ]. Activation of reverse transcriptase RT takes place in the cytoplasm.
This proviral DNA is transported via nucleopores into the cell nucleus in the form of a complex consisting of the integrase IN and linear or circular proviral DNA. The integrase then inserts at random the proviral genome into the human host cell genome. Integration of the proviral DNA finalises the HIV infection of the cell and the establishment of a persistent infection. The proviral genome can be replicated together with and as part of the host cell genome during cell division latent infection which seems to be rare.
The synthesis of full-length viral mRNA is regulated among others by Tat and maximally accelerated by Tat p14 [ 44 ]. The attachment of HIV to a CD4-positive cell requires around 30 min up to 2 h, the transcription of the viral RNA genome into the proviral DNA is completed after approximately 6 h, and the integration into the host genome takes an additional 6 h.
After integration, the first virus particles are detectable after approximately 12 h; i. Because the viral RT has no proofreading activity, statistically one incorrect nucleotide per transcription round is incorporated into the proviral DNA.
If HIV replication is unrestricted a daily turnover of 10 8 9 viral particles is expected, i. Assuming a mutation rate of 1 in 10 4 nucleotides per genome during one replication cycle, a broad spectrum of various quasispecies can therefore develop in a patient in the course of time. Since epitopes for neutralising antibodies are also affected by mutation, these quasispecies are able to continually evade the immune system, infect new cells and therefore maintain HIV production [ 25 , 29 ].
Not all nucleotide changes result in the exchange of an amino acid. However, mutations in essential regions of the structural proteins or influencing active centres of enzymes give rise to replication-incompetent HIV mutants. Infected T lymphocytes are eliminated with a half-life of days from the blood of an HIV-infected person by cytotoxic HIV components, lysis of virus-producing cells or by cytotoxic T lymphocytes as part of the immune response [ 48 , 49 ].
Since HIV-infected T helper cells are also lysed and the production of such cells is inhibited simultaneously, a gradual decline of T helper cells is observed. HIV-specific proteins like Nef and Tat are responsible for insufficient maturation and replacement of T helper cells [ 29 ].
Therefore, part of the newly produced T helper lymphocytes do not develop normal functions [ 47 ]. After a long-lasting HIV infection the continuous loss of T helper lymphocytes results in immunodeficiency. HIV integrated into the host genome of long-lived cells like macrophages, astrocytes or memory T cells can persist in the latent stage for several years half-life of certain target cells is 7 years.
Activation of such cells results in the production of infectious HIV particles. The lipid envelope primarily characterises the stability of HIV. HIV is stable for several hours at a pH between 3 and 10 [ 50 , 51 ]. HIV is sensitive against disinfectants. HIV is stable over several hours against the influence of physical conditions like ultraviolet light, gamma irradiation or ultrasonic waves [ 53 , 54 ]. In contrast to other viruses, treatment of platelet concentrates with UVC light reduced HIV titres only slightly [ 55 ].
Therefore in a blood donation only a titre reduction of 1. Taking into consideration that one human infectious dose HID corresponds to approximately , HIV particles, a small amount of transfused blood is sufficient to transmit an HIV infection, although exceptions were observed occasionally [ 58 ].
The infectivity of HIV particles in lymphocytes is variable. It has to be assumed that processed HIV in lymphocytes is inactivated more rapidly than in plasma. In dendritic cells HIV can remain infectious for several weeks [ 41 ].
In lyophilised plasma or factor concentrates, HIV is stable at room temperature for years in the presence of high protein concentrations. HIV is able to enter the body via intact mucous membranes, eczematous or injured skin or mucosa and by parenteral inoculation.
When transmitted by sexual contact, HIV attaches first to dendritic cells e. HIV is taken up by macrophages and replicated [ 60 ] as shown for M cells in the mucosa [ 61 ]. HIV exposure to blood cells can result in the direct infection of T helper cells and the transmission of R5 and X4 viruses using CXC4 receptor as a co-receptor [ 62 ]. As mentioned above, 1 HID is equivalent to approximately , HIV particles, with a higher dose required for infection via mucous membranes compared to infection via the bloodstream, e.
The majority of new HIV infections are still transmitted sexually. Another epidemiologically relevant route is parenteral administration of drugs and also snorting of drugs with epistaxis. One to two days after infection HIV can be detected in regional lymphatic tissue [ 63 ] and within days in regional lymph nodes. After days post infection HIV can be detected in the whole body, including the nervous system.
Differences in the rate of dissemination of HIV in the body have been observed, depending on the primary target cells infected, e. Within an infected organism, distinct compartments can be distinguished by means of virus concentration; however, no correlation between virus concentrations in the different compartments is obvious. HIV-relevant compartments are blood and the cerebrospinal and genital systems ejaculate or vaginal secretion [ 65 , 66 ]. Transmission of HIV via blood or transplanted organs, including bone, is possible from about days after infection of the donor.
HIV can be transmitted via breast milk [ 68 ]. These symptoms are non-specific and are also found in other viral infections such as EBV- and CMV-induced mononucleosis or influenza.
Acute neuropathy is common in the acute phase. The symptoms persist for weeks. This initial symptomatic phase is usually followed by an asymptomatic phase or one with occasional symptoms which can last for many years. Therefore blood donations are highly infectious during this phase.
However, in this phase blood and cervicovaginal secretions or seminal fluids of infected persons are still infectious. Diagram of the temporal course of an untreated HIV infection. The time scale is initially weeks acute phase , then months and finally years stages 2 and 3. The key feature of viraemia is the undulation after the initial uninhibited HIV replication. The CD4 cell count decreases over time despite repeated recovery phases. HIV antibodies remain measurable for life, and the decrease of antibody response in stages 2 and 3 results from loss of core antibodies anti p55, p24 and p The overall interval from infection with the virus to the onset of AIDS may vary without therapy from 2 to 25 years or longer.
Depending on the immune response and the test systems used, the commercially available antibody screening tests are able to detect HIV-specific antibodies in the plasma approximately as of the third week post infection, typically after weeks and in the case of a delayed immune response after 8 weeks see 1.
At the beginning of the immune response low titres of IgM and IgG antibodies are detectable that are mainly directed against p24 and the surface glycoproteins gp and gp Subsequently, high-avidity IgG antibodies against all HIV proteins are developed, typically within weeks.
A specific T-cell response is induced against a variety of epitopes of HIV proteins [ 76 ]. Like in other virus infections, the early immune response leads to an IgM antibody response that can persist for months [ 5 ].
A high portion of the neutralising antibodies is directed against the V3 loop of gp Such antibodies are strain-specific and are not able to sufficiently eliminate all HIV quasispecies which are continuously produced in the infected individual [ 25 , 77 , 78 ]. Under the pressure of the immune response, viruses with a variable V3 loop are selected. The V3 loop is the region of the gp protein hypervariable region in which high numbers of mutations are observed, resulting in amino acid exchanges.
No serologic subtype differentiation is possible, but this can be achieved by determining the subtype-specific amino acid sequences of the C2V5 region of gp [ 8 ]. In the course of the HIV infection and depending on the number of CD4 cells, at first unspecific symptoms can be observed. These can include short episodes of fever, diarrhoea, malaise, fatigue and loss of weight symptoms of the so-called AIDS-related complex, ARC.
Characteristic features of an HIV infection are periods of good health followed by periods of illness which become more frequent and longer-lasting in the course of the infection [ 79 , 80 ]. Time to occurrence of apparent symptoms of immunodeficiency varies from 2 to 25 years or more fig. As mentioned above, impairment of neurologic and cerebral functions can emerge at any stage of infection.
Frequently occurring opportunistic pathogens are Toxoplasma gondii , Cryptosporidium parvum , Pneumocystis jirovecii , Mycobacterium tuberculosis and atypical mycobacteria, Salmonella spec.
Patients with HIV infections lasting for years develop marasmus which is a characteristic outward manifestation of untreated patients [ 5 ]. Concurrent infection with hepatitis C virus HCV results in faster progression of both virus-induced diseases [ 81 , 82 , 83 ]. Some HIV-infected patients develop characteristic atrophic skin alterations or seborrhoeic eczema that are visible manifestations of the HIV infection.
Likewise at an early stage of the infection changes of the oral mucosa are detectable, with gingival retraction and deep periodontal lesions as well as hairy leucoplakia on the lateral rim of the tongue or on the buccal mucosa [ 84 ]. Subdivision includes the CD4 cell count. According to present knowledge, the spread of HIV started at the beginning of the 20th century [ 4 , 86 ]. HIV-2 was transmitted zoonotically from sooty mangabey Cercocebus atys to human in West Africa around [ 87 ].
Molecular genetic analyses suggest that HIV-1 was exported to Haiti probably in and arrived in North America approximately 2 years later [ 4 , 88 ]. Since the mids the different HIV-1 M subtypes have been spreading, leading to a global pandemic.
Globally, an estimated 35 million people were living with HIV in [ 89 ]. Since the number of new infections has been decreasing continuously, and for a number of 1. About three quarters of HIV-infected persons live in Sub-Saharan Africa, and also about two-thirds of the reported new infections originate from this region.
The data on the HIV epidemic in Germany are mainly based on the implemented obligatory reporting system. Reporting must be performed by the diagnosing laboratory also the diagnosing blood establishment. The physician submitting the specimen receives a copy of the reporting form. The physician is required to supply demographic, anamnestic and clinical data which are not available to the laboratory. The completed reporting form is sent directly to the Robert Koch Institute.
The available surveillance instruments provide data on specific aspects of the HIV epidemic. Therefore, the Robert Koch Institute regularly generates estimations of the course of the HIV epidemic, taking into account the available data and information from the various sources.
Determination of the number of new HIV infections per time unit HIV incidence by means of official reporting data is not possible because the reports of HIV diagnoses do not allow direct conclusions about the date of infection. HIV incidence and HIV prevalence cannot be measured directly but only estimated by means of model projections.
At first, the estimated number of new HIV infections in all age groups has decreased significantly in the course of time up to the end of the s, with peak values in the mids.
From to around a significant increase of HIV infections was observed, with a plateau since Approximately women In addition, HIV infections were observed in about 9. The trends in the three main groups affected in Germany proceeded differently: the first peak of infections occurred simultaneously in the groups of MSM and IVD in the mids. In the following years up to the beginning of the s, the number of new HIV infections decreased significantly in both groups. This trend continued in the group of IVD up to with a largely constant low level of new infections since Also in the group of MSM significantly fewer infections occurred during the s.
However, in the period between and a significant increase in HIV infections in MSM was observed and reached a considerably higher plateau in The number of those infected via heterosexual contacts hetero-domestic in Germany has been rising significantly slower in the course of the epidemic than in the MSM and IVD groups. Since the number of new infections in heterosexually infected persons has remained on a constant level.
Autonomous heterosexual infection chains have a minor impact on the spread of the HIV epidemic in Germany. Considering the number of reported new infections, large regional differences can be observed. Especially in densely populated urban areas among others Rhine-Ruhr, Rhine-Main and major cities, the incidence of new diagnoses is much higher than in the remaining regions. In , the ratio of men to women in the group of new infections was 3.
Since the percentage of newly diagnosed cases has been rather stable. In Eastern Europe i. Newly diagnosed HIV infections and modes of transmission in different European countries in www. The molecular epidemiologic data show that HIV-1 group M subtypes have different regional prevalence patterns. The prevalence of HIV-1 subtypes and HIV-2 in European countries reflects the historic connection of these countries to the corresponding endemic regions in Africa [ 12 , 17 , 93 ].
Africa is the continent that is affected most by HIV infections. The estimated HIV prevalence in Africa varies widely and lies between 0. Heterosexual contacts are the main route of infection in Africa, and sex work and sexual violence contribute significantly to the spread of the disease.
Approximately one third of those infected with HIV received antiretroviral therapy in [ 89 ]. In Asia, about 1. The epidemic is concentrated in distinct groups with a high risk of exposure, such as MSM, sex workers, drug users and transsexuals [ 89 ]. This is a further indication for the continuous evolution of HIV-1 group M in humans.
The main mode of transmission is sexual contact among men [ ]. At the beginning of the epidemic the prevalent subtype B strain had a defect in Nef and a lower pathogenicity [ ].
Approximately 1. The main route of transmission is sexual contact between men. About one third of all persons infected with HIV receive antiretroviral therapy [ ]. In Canada, 2, new HIV infections were reported in , the lowest number determined since introduction of the reporting system in In Canada also, MSM represent the mainly affected group.
In Latin America, approximately 1. Further recombinants are found in Brazil and in neighbouring countries [ 16 ]. A general distinction can be made between two principles of detection: antibody and virus detection. HIV antibody screening tests are used for the primary diagnosis followed by a confirmation test in the case of a reactive result in the screening assay.
In addition to the ELISA enzyme linked immunosorbent assay or variants of this test system, particle agglutination tests are used. Depending on the manufacturer, additional antigens derived from the reverse transcriptase and the p24 protein are included in the test systems [ 11 , , , ]. Depending on the immune response and the antibody titre, an infection can be detected serologically after 3 weeks but usually after weeks [ ]. In rare cases, HIV-infected individuals with complete immunosuppression might be HIV antibody-negative, but they have HIV-typical clinical symptoms and measurable virus titres in the blood [ ].
Because ELISAs were developed also for the detection of low antibody levels with the highest sensitivity, false-positive results occur, especially when immune complexes are present in the serum, e. Furthermore, false-positive results were reported for individuals with autoimmune diseases or allergies and for pregnant women. Mistakes in pre-test conditioning can lead to false-positive screening tests, e.
Since the information about a positive HIV finding has far-reaching consequences for the infected individual, it is recommended in cases of a positive result in the initial analysis to test a second, independently taken blood sample. In the same sample the amount of viral genomes viral load should also be determined using NAT in order to identify the need for antiviral treatment [ , ].
Virus isolation in cell culture takes approximately 6 weeks and is often unsuccessful and costly. For diagnostics in blood establishments virus isolation is of no relevance. The p24 protein forms the inner capsid. Each virus particle contains approximately 2, p24 molecules [ ]. Detection of p24 antigen is performed using a combination of polyclonal or monoclonal antibodies, following the principle of the sandwich ELISA technique.
0コメント